Want to join the conversation?
$ADSK's revenue from flagship products represented 45% of total net revenue during FY16 and declined by 5% compared to FY15. Revenue from suites represented 37% of total net revenue for FY16 and remained flat compared to FY15. Revenue from new and adjacent products represented 18% of total net revenue during FY16 and grew by 12% versus FY15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?